This RCT compared telehomecare monitoring to usual skilled home care for heart failure patients (55+) after hospital discharge. While telehomecare patients showed lower readmission rates at 30 days (16% vs 19%) and 6 months (46% vs 52%), the difference wasn't statistically significant. However, telehomecare patients had significantly better access to care and satisfaction, including more in-person visits. The authors conclude that patient acceptance of the technology and existing home-care processes limited the intervention's full clinical impact.Reader will learn about Why promising telehealth interventions don't always translate into statistically significant clinical outcomes, how access-to-care and patient satisfaction can improve even when readmission numbers don't move dramatically, and why technology adoption barriers (not just the tech itself) often determine real-world effectiveness.
Research
Clinical Effectiveness, Access to, and Satisfaction with Care Using a Telehomecare Substitution Intervention: A Randomized Controlled Trial
Hospitalization accounts for 70% of heart failure (HF) costs; readmission rates at 30 days are 24% and rise to 50% by 90 days.
Continue Reading